Fig. 1From: Effects of endoscopic injection sclerotherapy for esophagogastric varices on portal hemodynamics and liver functionFlowchart for patient selection. Between November 2001 and November 2016, 224 patients with EGV were treated with EIS. We excluded 123 patients with hepatocellular carcinoma. Eventually, 58 patients who provided written informed consent, were enrolled in this study. We divided patients into two groups, namely increased group (IG) and decreased group (DG) following endoscopic sclerotherapyBack to article page